top of page
About
Technology
Vaccine Pipeline
News
Contact
More
Use tab to navigate through the menu items.
All Posts
Press Releases
In the News
Search
Meissa Vaccines Begins Study of RSV Vaccine Candidate in Seronegative Children
Jun 30, 2021
BioPharm International: Modernizing Intranasal Live Attenuated Vaccines
Jun 21, 2021
Biotech 2050 Podcast: An End Game Vaccine for COVID-19
May 24, 2021
Meissa Vaccines Appoints Dr. Michael Watson to Board of Directors
Apr 13, 2021
BioSpace: Meissa’s Intranasal COVID-19 Vaccine Uses Codon Deoptimization for Stronger Responses
Mar 24, 2021
Meissa Announces IND Clearance for Phase 1 Study of COVID-19 Intranasal Live Attenuated Vaccine
Mar 16, 2021
Meissa Announces 1st Dosing in Phase 2 Study of Intranasal Live Attenuated Vaccine Candidate for RSV
Jan 21, 2021
Meissa Vaccines Expands Leadership Team as Company Advances Intranasal RSV and COVID-19 Candidates
Oct 14, 2020
San Francisco Business Times: Covid Vaccine Player Hopes to Start Clinical Trial Early Next Year
Jul 30, 2020
BioSpace: Another COVID-19 Vaccine Joins the Race – This Time, it’s a Live, Weakened Virus
Jul 20, 2020
Meissa Vaccines Provides a Pipeline Update on Vaccine Candidates for COVID-19 and RSV
Jun 30, 2020
Meissa Vaccines Receives U.S. FDA Fast Track Designation for Respiratory Syncytial Virus Vaccine
Jan 10, 2020
FierceBiotech: Meissa Raises $30M to Take RSV Vaccine into the Clinic
Sep 26, 2019
Meissa Vaccines Closes $30 Million Financing to Advance RSV Vaccine into Clinical Trials
Sep 26, 2019
Xconomy: Meissa Scores $30M to Test Vaccine for Dangerous Respiratory Virus
Sep 26, 2019
Endpoints: Meissa Obtains $30M Series A to Test Synthetic Biology Approach to 'Elusive' RSV Vaccines
Sep 26, 2019
Meissa Vaccines Closes $3.4 Million Financing to Advance RSV Vaccine to Clinic
Mar 27, 2019
Meissa Vaccines Announces Seed Round Investment from FundRx
Aug 3, 2017
Meissa Vaccines Awarded NIH SBIR Grant to Advance IND Preparations for RSV Vaccine Candidate
Jul 12, 2017
Meissa Vaccines Receives FDA Clearance of IND Application, Phase 1 Clinical Trial of MV-012-968
Jul 12, 2017
Meissa Awarded NIH SBIR Grant to Support Development of Multivalent Human Rhinovirus Vaccine Candida
May 10, 2017
bottom of page
